James Taylor is an associate in the firm’s Business Law Department and a member of its Technology and Life Sciences group. Mr. Taylor helps clients buy, sell, license, use and protect technology and intellectual property in both business and consumer facing environments.

Mr. Taylor has a wide range of experience but focuses on financial services (with an emphasis on blockchain, cryptocurrencies and payments) and life sciences sectors, where he assists established clients and start-ups navigate complex regulatory regimes. He also regularly advises on data privacy issues and compliance with the General Data Protection Regulation.

Mr. Taylor drafts and negotiates agreements relating to blockchain technology, medical devices, drug patents and clinical trials, software development (both agile and waterfall development methodologies) and licensing, data creation, licensing and distribution, traditional and cloud outsourcing (including in the regulated sector), website and app terms and privacy/cookie policies.





Representative Matters



Mr. Taylor's recent experience advising on fintech matters include:
  • an established cryptoasset wallet provider and exchange on the release of its first loyalty token.
  • a software company on the regulatory classification of a stablecoin issued to facilitate payments in the telecommunications industry.
  • advising in respect of the application of strong customer authentication under PSD2 when one of the parties is established outside of the European Union.
  • the venture capital firms backing one of the largest global blockchain payment systems operated by a foundation in Switzerland.
  • a provider of cryptoasset derivatives on its appointment of an authorised representative regulated by the FCA.
  • a financial market data platform in respect of the development and protection of its intellectual property.
  • a fintech company on its set-up and running of a private blockchain utilised by a consortium of financial services companies to clear and settle payments.*
  • a government in respect of regulating distributed ledger technology and drafting new laws to give blockchain technology “legal personality.”*
  • a Swiss cryptocurrency exchange in respect of whether proposed utility tokens were specified investments under UK financial regulation, the financial promotions regime and AML/KYC requirements.*
  • a fixed-income trading platform with respect to repapering and negotiation of MiFID II compliant market rules and terms for participants, licensing platform technology to other exchanges in compliance with regulatory requirements (including audit, step-in rights and disaster recovery) and the purchase of transaction reporting services to ensure the platform and non-MiFID participants complied with MiFIR.*
  • an English multinational investment bank in relation to its data licensing requirements with over 50 stock exchanges globally.*
Mr. Taylor's recent experience advising on life sciences matters include:
  • an antibody drug conjugate technology provider on its collaboration and patent licensing arrangements.
  • a robotic surgery provider on its commercial arrangements in respect of its medical devices and data protection compliance in respect of patient health data.
  • negotiating commercial agreements on behalf of a NASDAQ listed company whose technology is revolutionizing the treatment of cancer.
  • assisting various pharmaceutical companies with the commercial arrangements regarding the operation of clinical trials and data protection issues in respect of such trials.
  • a multinational technology company’s wearables team in respect of a sub-study to a clinical trial involving the analysis of patient data and the differences between pseudonymisation and anonymisation of personal data*
  • an artificial intelligence company utilising deep learning (a branch of machine learning) in the optometry sector with respect to commercial and regulatory issues.*
Mr. Taylor's recent experience advising on software, hardware and data matters include:
  • a company utilising artificial intelligence in the scene detection sector on its complex licensing arrangements with several of the largest technology companies in the world.
  • complex distribution agreements relating to both hardware and software for a company operating in the internet of things and smart home sectors.
  • the commercial arrangements for a data business increasing efficiency in the construction industry.
  • various software businesses (and investors) in understanding and resolving potential open source software issues.
  • a FTSE 250 company that provides services to marine, oil and gas industries in relation to drafting its template bespoke software development agreement that incorporated schedules to reflect utilisation of both waterfall and agile development methodologies.*
  • one of the world’s largest technology companies on its purchase of office security system technology.

* Denotes experience prior to joining Goodwin.

Professional Activities

Mr. Taylor is a member of the Society for Computers and Law.

Professional Experience

Mr. Taylor has enjoyed secondments with legal tech start-up ThoughtRiver and the London Stock Exchange Group Plc. He helped the latter extensively with its Brexit-related projects, licensing of trading platforms and exploitation of financial market data.

Prior to becoming a solicitor, Mr. Taylor was an analyst with Allianz Insurance plc.

In The News









Legal Practice Course, 2014
The University of Law
LL.B., 2012
The University of Exeter



Solicitor of the Senior Courts of England and Wales
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique